Abstract:Objectives: The aims of the study were to determine the following: the status of glycemic control in patients with type 2 diabetes mellitus (DM) at primary, secondary, and tertiary hospitals in the Jiangsu province of China; and the factors associated with achieving glycemic targets.Methods: This study, in which patients were enrolled from July 20 to 31, 2009, at 56 diabetes centers, used a multiple-stage, stratified sampling method to select a representative sample of the population with DM in Jiangsu. The sampling process was stratified by geographic and demographic regions, and by the outpatient numbers in the hospitals. A primary hospital was defined as a community medical institution that provided primary health services; a secondary hospital was a local medical institution that provided comprehensive health services; and a tertiary hospital was a regional medical institution that provided comprehensive and specialist health services. In primary hospitals, patients with DM were treated by general physicians; at secondary and tertiary hospitals, they were seen by specialists. Also, primary and tertiary hospitals treated patients in cities, whereas secondary hospitals treated patients from towns or rural areas. Patients with a medical history of type 2 DM for >6 months and registration at each diabetes center for >= 6 months, and who were residents of Jiangsu province, were recruited. During the patient enrollment visit, information about DM complications and comorbidities, as well as DM management, was obtained by retrospectively reviewing medical records; basic patient data (eg, date of birth, sex, weight, height) were obtained by patient interview. Blood samples were collected for assessment of glycosylated hemoglobin (HbA(1c)) at a central laboratory.Results: Of 3046 sampled subjects, the analysis was performed in 2966 subjects with complete data. The mean (SD) HbA(1c) value for analyzed patients was 7.2% (1.6%). The proportion of patients with tight glycemic control was 40.2% (1193/2966) when a threshold of HbA(1c) <6.5% was used, and 56.1% (1665/2966) when a threshold of HbA(1c) <7.0% was used. Compared with patients who had inadequate glycemic control, those with tight control were younger (P < 0.001), had shorter duration of DM (P < 0.001), had lower body mass index (BMI) (P = 0.005 for HbA(1c) <6.5% and P = 0.01 for HbA(1c) <7.0%), had more education (P < 0.001) and income (P = 0.003 for HbA(1c) <6.5% and P = 0.008 for HbA(1c) <7.0%), were more likely to monitor their glucose (P = NS for HbA(1c) <6.5% and P = 0.043 for HbA(1c) <7.0%) and attend DM education (13, 0.027 for HbA(1c) <6.5% and P = 0.002 for HbA(1c) <7.0%) at least once a month, and were more likely to receive oral antidiabetic drugs (OADs) (P < 0.001). Age, BMI, and DM duration did not differ significantly between hospital types. Compared with primary (36.2%) and secondary hospitals (36.5%), tertiary hospitals (42.2%) had more patients with HbA(1c) <6.5% (P = 0.043); tertiary hospitals also had more patients with once-monthly glucose self-monitoring (P = 0.001), patients with higher income (P < 0.001) and education (P < 0.001), and those who were more likely to use OADs or insulin with OADs (P < 0.001).Conclusion: The overall status of glycemic control was unsatisfactory during the study period, although patients at tertiary hospitals appeared to have better control than those at primary or secondary hospitals. (Clin Ther. 2010;32:973-983) (C) 2010 Excerpta Medica Inc.

Survey of Glycemic Control in Type 2 Diabetic Patients Treated with Human Insulin in China

Glycemic and HbA1c controls of T2DM patients treated with human insulin in China

Glycemic Control among Patients in China with Type 2 Diabetes Mellitus Receiving Oral Drugs or Injectables

Glycemic control of adult patients with type 2 diabetes mellitus treated by oral antidiahetic drugs in combination with insulin in China in 2009

Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey

Glycaemic control in patients with type 2 diabetes treated with oral antidiabetic drugs in urban areas of China

Status of Blood Glucose Control and Treatment of Type 2 Diabetes in China

Status of Basal-Supported Oral Therapy in Chinese Type 2 Diabetic Patients with Inadequate Glycemic Control on Oral Anti-Diabetic Drugs

Investigation of glycemic control and antidiabetic therapy in type 2 diabetic patients in Jiangsu province

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.

Inadequate Glycaemic Control and Antidiabetic Therapy among Inpatients with Type 2 Diabetes in Guangdong Province of China.

China type 2 diabetes treatment status survey of treatment pattern of oral drugs users

Management of Chinese Patients with Type 2 Diabetes, 1998-2006: the Diabcare-China Surveys

PDG8 EFFICACY OF PHARMACOLOGICAL MONOTHERAPIES FOR TYPE 2 DIABETES IN CHINA

PP93 Efficacy of Pharmacological Treatments for Type 2 Diabetes in China

Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone

Factors Associated with Glycemic Control in Type 1 Diabetes Patients in China: A Cross‐sectional Study

The Risk Factors of Glycemic Control, Blood Pressure Control, Lipid Control in Chinese Patients with Newly Diagnosed Type 2 Diabetes _ A Nationwide Prospective Cohort Study.

The Status of Glycemic Control: A Cross-Sectional Study of Outpatients with Type 2 Diabetes Mellitus Across Primary, Secondary, and Tertiary Hospitals in the Jiangsu Province of China

A nationwide survey of diabetes education, self-management and glycemic control in patients with type 2 diabetes in China.

Efficacy and Safety of Additional Basal Insulin or Oral Antidiabetic Drug in Type 2 Diabetes Poorly Controlled with One Oral Antidiabetic Drug